skip to main | skip to sidebar

The Health, Drug, Prescription, and GMP Supersite

Thoughts and resources about health, drugs and prescriptions, and how they are affected by GMPs (FDA Good Manufacturing Practices) and other regulations.

Saturday, February 19, 2022

U.S. Senate narrowly confirms Dr. Robert Califf to lead FDA for second time – Reuters

  • Respected FDA GMP online training courses and programs by SkillsPlus International Inc.

U.S. Senate narrowly confirms Dr. Robert Califf to lead FDA for second time – Reuters

Robert M. Califf, M.D., is Commissioner of Food and Drugs. President Joe Biden nominated Dr. Califf to head the U.S. Food and Drug Administration and Dr. Califf was sworn in on February 17, 2022. Previously, Dr. Califf served as Commissioner of Food and Drugs from February 2016 to January 2017. Image of Dr. Califf.

Welcome Back, Commissioner Califf! Robert M. Califf, M.D., was sworn in as the Commissioner of Food and Drugs on February 17, 2022. – FDA.gov

Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Posted by Austin Lee at 11:52 AM
Labels: califf, cgmp, commissioner, courses, fda, gmp, online, programs, training

1 comment:

Austin Lee said...

On the FDA website, Robert M. Califf M.D., MACC |
COMMISSIONER OF FOOD AND DRUGS - FOOD AND DRUG ADMINISTRATION

February 19, 2022 at 1:20 PM

Post a Comment

Newer Post Older Post Home
View mobile version
Subscribe to: Post Comments (Atom)

From SkillsPlus International Inc.

Loading...
  • Home
  • SkillsPlus Intl Inc - The Leader in QSR & GMP Training
  • Popular FDA, cGMP, QSR, & GMP Training Courses
  • The Best Exemptee & Designated Representative Training Courses - Online Self-Study
  • CA HMDR Exemptee Certification Class
  • California Exemptee Certification - State Approved
  • The Exemptee Institute
  • The Designated Representative Institute
  • SkillsPlus Intl Inc Blog
  • Home Medical Device Retail - California HMDR Exemptee Training Certification Course
  • Designated Representative Online Training Courses

California Designated Representative Training


Designated Representative Wholesaler Training Course

Designated Representative 3PL Training Course

Designated Representative Reverse Distributor Course


SkillsPlus International Inc. is the ONLY training provider approved by the California State Board of Pharmacy to offer California Designated Representative training programs for wholesalers, 3PL, and reverse distributors. Nearly 10,000 students have taken our state license-related training courses! #2025 #2026 #2027

CA Designated Rep 3PL Course

CA Designated Rep 3PL Course
California Designated Representative 3PL Online Training Course. #2025

The Best Exemptee Training



Sign-up for Exemptee training now!


California HMDR Exemptee license online training certification class for home medical device retailers. Earns a course completion certificate accepted by the California Department of Public Health - Food and Drug Branch. We've added something new, closed captioning. Students can read what the course instructor is teaching. Nearly 10,000 students have taken our state license-related training courses! This feature helps ESL (English as a second language) students, and hard of hearing students. #2025 #2026 #2027

CGMP Online Training Courses

CGMP Online Training Courses
Current Good Manufacturing Practice Training: A New Generation Series - CGMP Online Courses

GMP Trainer Courses

GMP Trainer Courses
GMP Trainer Awareness, Certification, and Master Trainer Courses

Root Cause Analysis - cGMP Training

Root Cause Analysis - cGMP Training
cGMP Training - Online Self-Study Course - Root Cause - Investigation Reports

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments
Subscribe to The Health, Drug, Prescription, and GMP Supersite by Email

Blog List

  • NPR Blogs: Shots - Health News Blog
    Trump administration ends 988 Lifeline's special service for LGBTQ+ young people
    2 hours ago
  • Wellness Blog - NY Times
    How to Improve Your Self-Control
    4 hours ago
  • All Kaiser Health News
    Journalists Dig Into Megabill’s Slashing of Medicaid. Plus, How To Avoid Tick Bites.
    4 hours ago
  • Marler Blog
    Busy week for FDA – Salmonella and Cyclospora galore
    8 hours ago
  • FDA - Press Releases
    FDA Requests Sarepta Therapeutics Suspend Distribution of Elevidys and Places Clinical Trials on Hold for Multiple Gene Therapy Products Following 3 Deaths
    14 hours ago
  • Medtech Insight
    Device Sterilization Plants Get Extra 2 Years To Comply On EtO Phase-Out
    15 hours ago
  • Food Poison Journal
    Popsicles recall due to Listeria risk
    16 hours ago
  • CNBC Health Care
    Sarepta shares plunge 40% as future of its gene therapy appears at risk
    18 hours ago
  • eLearning Industry
    Thought Leader Q&A: Talking Learning Sciences In Instructional Design And Real-World Skill Building With Dr. Jerry Zandstra
    18 hours ago
  • FierceBiotech: Medtech
    Coronary AI diagnostic developer Heartflow files $100M IPO
    19 hours ago
  • Pharmaceutical Commerce
    How DSCSA Is Transforming Supply Chain Data Exchange (Episode 4)
    19 hours ago
  • BioPharma Dive - Latest News
    FDA to ask Sarepta to stop shipping Duchenne gene therapy
    19 hours ago
  • BioPharma Dive
    FDA to ask Sarepta to stop shipping Duchenne gene therapy
    19 hours ago
  • Government Executive
    Census has long struggled with staffing shortages. Employees say Trump is making it worse
    19 hours ago
  • Medscape Today Headlines
    Career Pivot: A Physician's Guide to What's Next
    19 hours ago
  • GEN Biotech News
    GenesisM Breaks Ground on its New Biomanufacturing Facility in the Greater Boston Area
    20 hours ago
  • Pharmalot – STAT
    STAT+: Up and down the ladder: The latest comings and goings
    21 hours ago
  • FDA What's New: Drugs
    E21 Inclusion of Pregnant and Breastfeeding Women in Clinical Trials
    22 hours ago
  • Clarkston Consulting
    Key Considerations When Planning Your Clinical Trial Data Migration
    1 day ago
  • FierceBiotech
    FDA mulls Elevidys market withdrawal following 3rd death after a Sarepta gene therapy
    1 day ago
  • FiercePharma
    FDA mulls Elevidys market withdrawal following 3rd death after a Sarepta gene therapy
    1 day ago
  • Pharmafile
    Johnson & Johnson submits FDA application for Caplyta to prevent schizophrenia relapse
    1 day ago
  • Drug & Device Law
    Snap! Sometimes the Third Time Isn’t a Charm
    1 day ago
  • Science-Based Medicine
    As Diseases Spread and Trust in the FDA Crumbles, Its Leaders Are Obsessed with an MRI Abnormality in 1 in 61,500 Males Ages 12-24
    1 day ago
  • JD Supra Law News
    AGG Supports GHA and MAG in Latest Successful Step to Cap Wrongful Death Damages
    3 days ago
  • Drug Channels
    Gross-to-Net Bubble Hits $356B in 2024—But Growth Slows to 10-Year Low
    4 days ago
  • World Pharma - Breaking News
    Researchers develop potent CDK9 inhibitor to overcome drug resistance in hematological malignancies
    1 week ago
  • Mobihealthnews
    Mendaera gets FDA 510(k) clearance for handheld robotic system
    1 week ago
  • Healthcare Packaging
    Study Reveals the U.S. Pharmaceutical Firms with the Most FDA Recalls
    1 week ago
  • Pharmafile - Mfg & Production
    LEO Pharma appoints Helle Hedegaard Juhl as EVP of global people & corporate affairs
    1 week ago
  • The Incidental Economist
    Older Americans Backing Trump Now Face Cuts to Medicaid, Services
    2 weeks ago
  • Asbestos and Mesothelioma News
    Asbestos Ban Future Is Uncertain
    3 weeks ago
  • Clinical Correlations
    How Can We Better Protect Our Patients Against Extreme Heat?
    3 weeks ago
  • Ted Eytan, MD
    Nova Exhibition
    4 weeks ago
  • The Compliance and Ethics Blog
    Mark Diamond on Rethinking Records Retention [Podcast]
    5 weeks ago
  • SkillsPlus International Info
    FDA Rushed Out AI Tool
    1 month ago
  • The Health, Drug, Prescription, and GMP Supersite
    Designated Representative Training - California | State-Approved
    1 month ago
  • Modern Healthcare News
    Meet the Administration for a Healthy America, HHS' newest agency
    1 month ago
  • Quality Matters
    A path to locally manufactured quality medicines: Building capacity in Africa to conduct bioequivalence studies
    1 month ago
  • Designated Representative and Exemptee
    Designated Representative Training | Board-Approved Courses | Recommended
    3 months ago
  • Pharma IQ Regulatory-Legal
    AI-Driven Productivity Gains: Transforming Pharma Supply Chain Efficiency
    4 months ago
  • FDA – Policy & Medicine
    FDA Releases Draft Guidance on the Accelerated Approval Process
    4 months ago
  • BioPharma-Reporter RSS
    Inhibikase to pause development of Parkinson’s drug
    5 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    5 months ago
  • Outsourcing-Pharma
    Ethris reports positive phase 1 results for asthma mRNA therapy
    5 months ago
  • 33 Charts
    AI and LinkedIn Writing as a Commodity
    5 months ago
  • Biotech Blog
    Making Medicines Affordable: The Role of Generics
    6 months ago
  • FDA - Health Fraud
    27 Individuals Indicted for Buying and Selling Wholesale Quantities of Misbranded and Diverted Prescription Drugs Resold to the Public Through Retail Pharmacies in Puerto Rico
    9 months ago
  • BioSpace Regulatory News
    FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm
    11 months ago
  • Healthy Travel Blog
    Hello world!
    1 year ago
  • Quality Digest - FDA Compliance
    Nine Strategies for Effective Internal Audits
    1 year ago
  • Eye on FDA
    FDA Adds New AdComm to Address Genetic Metabolic Diseases
    1 year ago
  • Designated Representative Training Courses
    The Only Board-Approved California Designated Representative Training Programs For ...
    1 year ago
  • HMDR Exemptee Online Training
    California HMDR Exemptee Online Training Certification Course
    1 year ago
  • Medgadget
    Plant-Based Soft Medical Robots
    1 year ago
  • Drug Injury Watch
    Ozempic / Wegovy: Stomach And Intestinal Problems Can Be Irreversible, Life-threatening
    1 year ago
  • Golf Foodie
    More women in the U.S. are drinking themselves to death, research finds
    1 year ago
  • PharmaPhorum News
    Patient adherence – the key to restoring trust in pharma
    2 years ago
  • Pharma Manufacturing
    How pharma can overcome inflation
    2 years ago
  • Pharmaceutical Industry | Processing & Engineering: Knowledge, News and Analysis | Pharmaceutical Manufacturing
    How pharma can overcome inflation
    2 years ago
  • CA Designated Rep Training
    Recommended! California Designated Representative Online Training Courses
    5 years ago
Show 5 Show All

Blog Archive

  • ►  2025 (1)
    • ►  June (1)
  • ►  2024 (5)
    • ►  August (1)
    • ►  July (1)
    • ►  May (1)
    • ►  March (2)
  • ►  2023 (6)
    • ►  December (1)
    • ►  October (2)
    • ►  July (1)
    • ►  May (1)
    • ►  January (1)
  • ▼  2022 (26)
    • ►  November (3)
    • ►  October (1)
    • ►  August (2)
    • ►  July (3)
    • ►  June (4)
    • ►  May (3)
    • ►  April (3)
    • ►  March (1)
    • ▼  February (3)
      • U.S. Senate narrowly confirms Dr. Robert Califf to...
      • The FDA’s Cigarette Health Warning Rule Is Postpon...
      • Yes, Mark Cuban did start a real online drugstore ...
    • ►  January (3)
  • ►  2021 (17)
    • ►  December (2)
    • ►  November (2)
    • ►  October (2)
    • ►  September (2)
    • ►  July (1)
    • ►  April (1)
    • ►  March (1)
    • ►  February (2)
    • ►  January (4)
  • ►  2020 (27)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (4)
    • ►  August (2)
    • ►  July (2)
    • ►  June (2)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  February (5)
  • ►  2019 (28)
    • ►  December (5)
    • ►  November (2)
    • ►  October (1)
    • ►  September (2)
    • ►  August (3)
    • ►  July (6)
    • ►  June (3)
    • ►  May (2)
    • ►  April (1)
    • ►  February (3)
  • ►  2018 (6)
    • ►  October (1)
    • ►  August (1)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  January (1)
  • ►  2017 (14)
    • ►  November (1)
    • ►  October (2)
    • ►  August (1)
    • ►  July (1)
    • ►  May (2)
    • ►  April (1)
    • ►  March (1)
    • ►  January (5)
  • ►  2016 (32)
    • ►  December (6)
    • ►  November (4)
    • ►  October (2)
    • ►  September (2)
    • ►  August (2)
    • ►  July (3)
    • ►  June (1)
    • ►  May (3)
    • ►  March (4)
    • ►  February (2)
    • ►  January (3)
  • ►  2015 (68)
    • ►  December (2)
    • ►  November (7)
    • ►  October (10)
    • ►  September (5)
    • ►  August (1)
    • ►  July (6)
    • ►  June (7)
    • ►  May (5)
    • ►  April (3)
    • ►  March (3)
    • ►  February (13)
    • ►  January (6)
  • ►  2014 (105)
    • ►  December (10)
    • ►  November (9)
    • ►  October (1)
    • ►  September (9)
    • ►  August (4)
    • ►  July (6)
    • ►  June (11)
    • ►  May (10)
    • ►  April (10)
    • ►  March (11)
    • ►  February (15)
    • ►  January (9)
  • ►  2013 (127)
    • ►  December (7)
    • ►  November (14)
    • ►  October (7)
    • ►  September (11)
    • ►  August (7)
    • ►  July (9)
    • ►  June (9)
    • ►  May (6)
    • ►  April (8)
    • ►  March (22)
    • ►  February (9)
    • ►  January (18)
  • ►  2012 (172)
    • ►  December (8)
    • ►  November (20)
    • ►  October (10)
    • ►  September (8)
    • ►  August (4)
    • ►  July (22)
    • ►  June (23)
    • ►  May (17)
    • ►  April (17)
    • ►  March (12)
    • ►  February (13)
    • ►  January (18)
  • ►  2011 (116)
    • ►  December (8)
    • ►  November (15)
    • ►  October (4)
    • ►  September (18)
    • ►  August (9)
    • ►  July (6)
    • ►  June (8)
    • ►  May (9)
    • ►  April (5)
    • ►  March (13)
    • ►  February (10)
    • ►  January (11)
  • ►  2010 (106)
    • ►  December (14)
    • ►  November (8)
    • ►  October (5)
    • ►  September (6)
    • ►  August (10)
    • ►  July (5)
    • ►  June (9)
    • ►  May (11)
    • ►  April (5)
    • ►  March (11)
    • ►  February (10)
    • ►  January (12)
  • ►  2009 (192)
    • ►  December (11)
    • ►  November (11)
    • ►  October (15)
    • ►  September (13)
    • ►  August (10)
    • ►  July (19)
    • ►  June (16)
    • ►  May (16)
    • ►  April (17)
    • ►  March (16)
    • ►  February (19)
    • ►  January (29)
  • ►  2008 (245)
    • ►  December (32)
    • ►  November (39)
    • ►  October (39)
    • ►  September (33)
    • ►  August (52)
    • ►  July (50)

Disclaimer & Privacy Policy

All data and information provided on this site is for informational purposes only. Drughealth.blogspot.com makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis. We use third-party advertising companies to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, click here.

SkillsPlus International Inc.

SkillsPlus International Inc.
SkillsPlus International Inc. Logo